You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
15 December 2025 - Biopharmaceutical company RedHill Biopharma Ltd (Nasdaq: RDHL) on Monday reported positive in vivo results showing that opaganib, when combined with venetoclax, reduced Chronic Lymphocytic Leukemia cell counts by 50% compared with ...
15 December 2025 - Finnish medical device company Bioretec Oy (HEL: BRETEC), which develops biodegradable orthopaedic implants, announced on Sunday that the US Food and Drug Administration had granted Breakthrough Device Designation for its magnesium...
15 December 2025 - Swedish medtech company Amferia, a developer of next-generation antimicrobial wound-care solutions, announced that it has closed an oversubscribed EUR3.5m investment round.The funding was led by existing shareholders alongside new ...
12 December 2025 - Swedish medical technology company Qlife Holding AB (STO: QLIFE), which develops the Egoo Health at-home diagnostics platform, said on Friday that its system will be used in a performance evaluation study led by Hipro Biotechnology...
12 December 2025 - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), a US-based biotechnology company focused on treatments for hereditary angioedema (HAE) and other rare diseases, said on Friday that it has received US Food and Drug Administration appr...
12 December 2025 - Copenhagen-based biotechnology company Genmab A/S (Nasdaq: GMAB) on Friday said that all conditions to its USD97-per-share cash tender offer for Dutch oncology company Merus NV (Nasdaq: MRUS) have been satisfied, enabling acceptanc...
12 December 2025 - NanOlogy, LLC, a Texas-based, private clinical-stage oncology company, announced on Thursday that it has launched a drug development program aimed at transforming the treatment of diffuse intrinsic pontine glioma (DIPG), an aggress...